medgator

Senior Member
15+ Year Member
Sep 20, 2004
4,808
1,625
Status
Attending Physician
Same. Or if there ends up being pN2/Stage IIIA+ disease post-op (4 or more nodes).
 
Last edited:

Palex80

RAD ON
10+ Year Member
Dec 17, 2007
1,447
362
39
Europe
Status
Attending Physician
We don't. We perform CT of the thorax and abdomen + bone scan for cN+ / pN+ patients, but PET is not being used in a regular basis for breast cancer.

Are there any data showing a clear advantage of PET vs. CT (with strategy changing implications)? I am aware of data in lung & esophagus, but I am not familiar with any in breast cancer.
 

medgator

Senior Member
15+ Year Member
Sep 20, 2004
4,808
1,625
Status
Attending Physician
We don't. We perform CT of the thorax and abdomen + bone scan for cN+ / pN+ patients, but PET is not being used in a regular basis for breast cancer.

Are there any data showing a clear advantage of PET vs. CT (with strategy changing implications)? I am aware of data in lung & esophagus, but I am not familiar with any in breast cancer.
There are some links provided in the NCCN guidelines to back up at least a Category 2B recommendation. The main take home point is that, like in Lung CA, PET/CT may better be able to assess and separate out the true Stage IV patients from others.

Here are a couple links:

http://www.ncbi.nlm.nih.gov/pubmed/20719497
http://www.ncbi.nlm.nih.gov/pubmed/15051773